Anbio Biotechnology NNNN
NASDAQ NNNN
$3.67 -0.06 (-1.47%)
As of: Oct 21, 2026 · 10:43 AM EDT

Anbio Biotechnology (NNNN) Receivables (2023 - 2025)

Updated

Anbio Biotechnology (NNNN) recorded Receivables of $3.66 million in the quarter ended Dec 31, 2025, up 243.4% from $1.06 million a year earlier.

Analysis

Anbio Biotechnology (NNNN) Receivables (2023 - 2025) Analysis & Trends

Starting with the quarter ended Dec 31, 2023, Anbio Biotechnology's Receivables history includes 4 quarters.

  • Across earlier years, Receivables came in at $1.06 million in the year ended Dec 31, 2024 (-43.5%) and $1.88 million in the year ended Dec 31, 2023.
  • Quarterly Receivables has ranged from $1.06 million in the quarter ended Dec 31, 2024 to $3.72 million in the quarter ended Jun 30, 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Thermo Fisher Scientific 258.38 Bn 237.41 Bn 4.88 Bn 11.14 Bn
2 Abbott Laboratories 171.98 Bn 142.41 Bn 7.27 Bn 8.60 Bn
3 Danaher 162.99 Bn 146.80 Bn 3.61 Bn 3.97 Bn
4 Intuitive Surgical 150.28 Bn 129.70 Bn 1.96 Bn 1.67 Bn
5 Medtronic 119.92 Bn 85.17 Bn 6.34 Bn 6.36 Bn
6 Stryker 113.47 Bn 99.59 Bn 4.50 Bn 3.74 Bn
7 Boston Scientific 65.06 Bn 59.83 Bn 3.85 Bn 3.05 Bn
8 Becton Dickinson 53.40 Bn 50.55 Bn 2.32 Bn 2.36 Bn
9 Edwards Lifesciences 50.64 Bn 34.65 Bn 1.35 Bn 955.70 Mn
10 Anbio Biotechnology 160.49 Mn 113.72 Mn - 3.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.66 Mn
Jun 30, 2025 3.72 Mn
Dec 31, 2024 1.06 Mn
Dec 31, 2023 1.88 Mn
API Access

Anbio Biotechnology Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=NNNN&period=max&api_key=YOUR_API_KEY